Project Grant R01GM156837

Award Date 6/1/25
Completion Date 3/31/29
Dollars Obligated $372K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Athens, GA 30602, USA
Similar Awards
This Project Grant award, with a total funding amount of $752,078, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award, effective July 29, 2024, and scheduled for completion by May 31, 2029, supports research by the University of Georgia Research Foundation, Inc. to investigate the epigenomic consequences of the breakage-fusion-bridge (BFB) cycle in complex eukaryotes like maize. The...
This $1,315,762 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to characterize the biogenesis and function of retrotransposon-derived circular DNA. The research aims to: 1) Determine how the alternative end-joining (Alt-EJ) DNA repair process mediates the circularization step in retrotransposon DNA replication; 2) Investigate how retrotransposon extrachromosomal...
This $362,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports a research project at North Dakota State University (NDSU) to understand the evolutionary dynamics between transposable elements and their host organisms. The key objectives are to investigate the forces that generate and maintain variation in the production of small RNA molecules (piRNA) used by organisms to defend against...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,545,538 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) effective July 12, 2024 through May 31, 2029. The grant supports research to define the mechanisms controlling the establishment, spreading, and epigenetic inheritance of Polycomb group (PCG)-repressed chromatin domains. Specifically, the project aims...
This $176,238 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a novel model to study the effects of LINE-1 retrotransposons on disease and normal physiology. The project aims to establish a reliable knockdown model using functionalized nanobodies to eliminate LINE-1 proteins, which are hypothesized to play a role in various diseases. The research will involve...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $423,500.00 to the University of Utah to conduct research aimed at understanding the genetic basis and molecular mechanisms of evolutionary conflicts and hybrid incompatibilities. The research program focuses on investigating the molecular arms races involving selfish genetic elements like segregation distorters and transposable...
This $388,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to better understand how the joint effects of selection and other evolutionary processes shape patterns of genomic variation. The research aims to generate improved estimates of the genome-wide fitness effects of new mutations, understand how selection against deleterious mutations affects variation in self-fertilizing...
This $231,141 federal Project Grant, awarded on August 1, 2024 by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), seeks to understand the process by which virus-derived genetic material can be integrated into host organisms such as insects and then utilized for the benefit of the host. The research will focus on multiple examples of these evolutionary processes, with the goal of discerning physiological and genetic patterns that lead to new traits and increased...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), aims to characterize the regulatory networks and mechanisms of retroelements (REs) in mammalian development and explore their therapeutic potential for diseases associated with epigenetic dysregulation. The $1,218,750 award, spanning from August 1, 2024 to May 31, 2029, will support a multi-faceted research effort led by the Trustees...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,192,500 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Pittsburgh to support research into how human-relevant biology evolved through the capture of viral genes by our distant ancestors. The key objectives are to: Leverage expertise in evolutionary biology, protein biochemistry, and B cell immunology to generate and disseminate high-quality reagents for studying endogenous...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research on the evolution and regulation of retrotransposons - a type of mobile genetic element - and their role in human health and disease. The $372,263 award to the University of Georgia Research Foundation, Inc. will fund a 4-year project from June 2025 to March 2029 to investigate novel mechanisms of retrotransposon control, including self-encoded copy number regulation, interactions between retrotransposon families, and the potential for horizontal transfer of retrotransposons between species. The research aims to provide insights into how organisms limit retrotransposon mobility and the consequences of retrotransposon dysregulation, which can contribute to human diseases. The project will combine experimental and computational approaches to advance the understanding of this fundamental biological process.

Generated 6/17/25, 3:03 AM